Data Sheet 1_Balloon-occluded hepatic arterial infusion for unresectable hepatocellular ca

An interim analysis from a phase II clinical trial (ChiCTR2300077718) assessing balloon-occluded hepatic arterial infusion chemotherapy for unresectable hepatocellular carcinoma. The dataset includes efficacy and safety outcomes for 50 patients, with results analyzed using SPSS version 27.0. The data was authored by Feng Li and last updated on June 1, 2026.

Use Cases

• Analyzing objective response rates based on RECIST and mRECIST criteria mentioned in the description
• Evaluating changes in alpha-fetoprotein (AFP) biomarker levels post-treatment
• Assessing the safety profile and adverse event management of the bHAIC-FO procedure

Strengths

• Includes data from 50 patients who received at least one successful bHAIC procedure
• Reports specific response rates: 53.3% ORR per RECIST 1.1 and 82.2% per mRECIST for 45 evaluable patients
• Documents a 77.3% rate of patients experiencing a >50% reduction in elevated AFP levels

Limitations

• Row count is unknown, which may limit suitability assessment
• Column-level documentation is absent; field semantics must be inferred after download
• Description metadata is limited; actual data quality requires manual inspection after download

Provenance

Source

figshare

Collection Method

Data collected from a multicenter, single-arm, prospective cohort clinical trial.

Freshness

Last updated 2026-06-01 04:17:34